Vyant Bio Inc Quick Ratio (VYNT) starting from the fourth quarter 2022 to fourth quarter 2021, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Vyant Bio Inc   (NASDAQ: VYNT)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Vyant Bio Inc 's Quick Ratio

VYNT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Vyant Bio Inc 's Cash & cash equivalent grew by 6.89 % in the Q4 2022 sequentially, while Current Liabilities decreased, this led to improvement in Vyant Bio Inc 's Quick Ratio to 2.74, above Vyant Bio Inc average Quick Ratio.

Within Medical Laboratories industry 22 other companies have achieved higher Quick Ratio than Vyant Bio Inc in fourth quarter 2022. While Quick Ratio total ranking has improved so far during the Q4 2022 to 1265, from total ranking in the third quarter 2022 at 1714.

Explain Quick Ratio?
How much Cash & cash equivalents VYNT´s has?
What are VYNT´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VYNT Quick Ratio (Dec 31 2022)
Q4		 (Sep 30 2022)
Q3		 (Jun 30 2022)
Q2		 (Mar 31 2022)
Q1		 (Dec 31 2021)
Q4
Y / Y Current Liabilities Change -32.52 % 43.35 % 61.86 % -4.06 % 68.14 %
Y / Y Cash & cash equivalent Change -51.28 % - - - 1415.29 %
Quick Ratio MRQ 2.74 1.4 1.56 2.2 3.79
VYNT's Total Ranking # 1265 # 1714 # 1762 # 1446 # 986
Seq. Current Liabilities Change -45.24 % -10.84 % 0.47 % 37.58 % 16.32 %
Seq. Cash & cash equivalent Change 6.89 % -19.72 % -28.82 % -20.23 % -



Quick Ratio fourth quarter 2022 Company Ranking
Within: No.
Medical Laboratories Industry # 23
Healthcare Sector # 611
Overall Market # 1265


Quick Ratio Statistics
High Average Low
14.14 2.28 0.02
(Jun 30 2014)  




Financial Statements
Vyant Bio Inc 's Current Liabilities $ 4 Millions Visit VYNT's Balance sheet
Vyant Bio Inc 's Cash & cash equivalent $ 10 Millions Visit VYNT's Balance sheet
Source of VYNT's Sales Visit VYNT's Sales by Geography


Cumulative Vyant Bio Inc 's Quick Ratio

VYNT's Quick Ratio for the trailling 12 Months

VYNT Quick Ratio

 (Dec 31 2022)
12 Months		 (Sep 30 2022)
12 Months		 (Jun 30 2022)
12 Months		 (Mar 31 2022)
12 Months		 (Dec 31 2021)
12 Months
Y / Y Current Liabilities TTM Growth 12.48 % 33.35 % 22.89 % -0.18 % 1.96 %
Y / Y Cash & cash equivalent TTM Growth 130.87 % 4175.29 % 1855.48 % 591.58 % 256.23 %
Quick Ratio TTM 1.88 2.15 1.94 1.67 0.91
Total Ranking TTM # 4732 # 4646 # 4630 # 4699 # 4777
Seq. Current Liabilities TTM Growth -6.52 % 8.07 % 12.92 % -1.4 % 10.83 %
Seq. Cash & cash equivalent TTM Growth -18.17 % 19.27 % 31.59 % 79.77 % 1415.29 %

Quick ratio ranking by company, industry and sector >> Back to VYNT Financial Strength Comparisons >> Go to Compare VYNT Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in VYNT's Current Liabilities to $3.67 millions, cumulative Quick Ratio to 1.88 above the company average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 52 other companies have achieved higher Quick Ratio than Vyant Bio Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2022 from 4646 to 4732.

Explain Quick Ratio?
How much Cash & cash equivalents VYNT´s has?
What are VYNT´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Laboratories Industry # 53
Healthcare Sector # 1188
Within the Market # 4732


trailing twelve months Quick Ratio Statistics
High Average Low
8.84 1.56 0.03
(Dec 31 2014)   (Jun 30 2019)




Companies with similar Quick Ratio in the quarter ending Dec 31 2022, within Medical Laboratories Industry Quick RatioDec 31 2022 MRQ Cash & cash equivalentDec 31 2022 MRQ Current Liabilities
Exagen Inc   7.27 $ 62.391  Millions$ 8.583  Millions
Castle Biosciences Inc   7.16 $ 258.625  Millions$ 36.128  Millions
Omniab Inc   6.78 $ 88.265  Millions$ 13.013  Millions
Science 37 Holdings Inc   5.69 $ 108.091  Millions$ 18.990  Millions
Sera Prognostics Inc   5.32 $ 82.704  Millions$ 15.538  Millions
Invitae Corporation  5.06 $ 547.100  Millions$ 108.093  Millions
Personalis Inc   4.49 $ 167.658  Millions$ 37.371  Millions
Caredx Inc   3.60 $ 293.089  Millions$ 81.411  Millions
Ispecimen inc   3.58 $ 15.336  Millions$ 4.281  Millions
Nano X Imaging Ltd  3.46 $ 102.822  Millions$ 29.722  Millions
Natera Inc   3.01 $ 898.392  Millions$ 298.504  Millions
Incyte Corporation  2.81 $ 3,238.965  Millions$ 1,153.898  Millions
Veracyte Inc   2.76 $ 154.247  Millions$ 55.931  Millions
Vyant Bio Inc   2.74 $ 10.041  Millions$ 3.665  Millions
Guardant Health Inc   2.58 $ 1,028.018  Millions$ 398.671  Millions
American Shared Hospital Services  2.41 $ 12.453  Millions$ 5.175  Millions
Burning Rock Biotech Limited  2.39 $ 131.582  Millions$ 55.029  Millions
Biocept Inc   2.34 $ 12.897  Millions$ 5.506  Millions
Absci Corp  2.32 $ 59.955  Millions$ 25.839  Millions
Aclarion Inc   2.14 $ 1.473  Millions$ 0.689  Millions
Biodesix Inc   1.89 $ 43.088  Millions$ 22.839  Millions
Exact Sciences Corporation  1.53 $ 632.057  Millions$ 412.651  Millions
Mdxhealth Sa  1.44 $ 15.503  Millions$ 10.794  Millions
WEED, INC.  1.34 $ 0.316  Millions$ 0.236  Millions
Bionexus Gene Lab Corp   1.07 $ 2.119  Millions$ 1.988  Millions
Psychemedics Corporation  1.01 $ 4.750  Millions$ 4.681  Millions
Fulgent Genetics Inc   0.90 $ 79.506  Millions$ 88.107  Millions
Centogene N v   0.90 $ 40.265  Millions$ 44.857  Millions
Foxo Technologies Inc   0.80 $ 5.515  Millions$ 6.913  Millions
Nrc Health  0.72 $ 25.026  Millions$ 34.974  Millions

Date modified: 2026-09-08T15:10:54+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.